当前位置:
X-MOL 学术
›
Nat. Rev. Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Haematological cancer: Blinatumomab facilitates complete responses
Nature Reviews Clinical Oncology ( IF 81.1 ) Pub Date : 2018-02-06 , DOI: 10.1038/nrclinonc.2018.24 Diana Romero
Nature Reviews Clinical Oncology ( IF 81.1 ) Pub Date : 2018-02-06 , DOI: 10.1038/nrclinonc.2018.24 Diana Romero
Haematological cancer: Blinatumomab facilitates complete responses
中文翻译:
血液癌症:Blinatumomab可促进完全反应
血液癌症:Blinatumomab可促进完全反应
更新日期:2018-02-06
Haematological cancer: Blinatumomab facilitates complete responses, Published online: 06 February 2018; doi:10.1038/nrclinonc.2018.24
Haematological cancer: Blinatumomab facilitates complete responses中文翻译:
血液癌症:Blinatumomab可促进完全反应
血液癌症:Blinatumomab可促进完全反应
血液癌症:Blinatumomab可促进完全反应,在线发布:2018年2月6日; doi:10.1038 / nrclinonc.2018.24
血液癌症:Blinatumomab可促进完全反应